64Cu-1,4,7,10-Tetraazacyclododecane- N, N', N'', N'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A)
- PMID: 20641208
- Bookshelf ID: NBK23001
64Cu-1,4,7,10-Tetraazacyclododecane- N, N', N'', N'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A)
Excerpt
Vascular endothelial growth factor (VEGF) consists of at least six isoforms with various numbers of amino acids (121, 145, 165, 183, 189, and 206 amino acids) produced through alternative splicing (1). VEGF121, VEGF165, and VEGF189 are the forms secreted by most cell types and are active as homodimers linked by disulfide bonds. VEGF121 does not bind to heparin like the other VEGF species (2). VEGF is a potent angiogenic factor that induces proliferation, sprouting, migration, and tube formation of endothelial cells. There are three high-affinity tyrosine kinase VEGF receptors on endothelial cells (VEGFR-1, Flt-1; VEGFR-2, KDR/Flt-1; and VEGFR-3, Flt-4). Several types of non-endothelial cells such as hematopoietic stem cells, melanoma cells, monocytes, osteoblasts, and pancreatic β cells also express VEGF receptors (1).
VEGF receptors were found to be overexpressed in various tumor cells and tumor-associated endothelial cells (3). Inhibition of VEGF receptor function has been shown to inhibit pathological angiogenesis as well as tumor growth and metastasis (4, 5). Radiolabeled VEGF has been developed as a tracer for imaging solid tumors and angiogenesis in humans (6-8). Alanine scanning mutagenesis in the corresponding domains in VEGF revealed that charged amino acid residues in two exposed domains of VEGF are involved in binding to VEGFR-1 (Asp63, Glu64, and Glu67) and VEGFR-2 (Arg82, Lys84, and His86), respectively. Wang et al. (9) prepared a D63AE64AE67A mutant of VEGF121 (VEGFDEE) by changing Asp63, Glu64, and Glu67 to Ala63, Ala64, and Ala 67 so that the mutant could bind preferably to VEGFR-2 over VEGFR-1. VEGFDEE was labeled with 64Cu via 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) for imaging VEGFR-2 expression in an orthotopic 4T1 murine breast tumor model to develop 64Cu-labeled DOTA-VEGFDEE (64Cu-DOTA-VEGFDEE) as a single-photon emission computed tomography (PET) imaging agent to study tumor angiogenesis.
Sections
Similar articles
-
64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121.2008 Feb 27 [updated 2008 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Feb 27 [updated 2008 Mar 22]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641821 Free Books & Documents. Review.
-
99mTc-Hydrazinonicotinic acid-single-chain Cys-tagged vascular endothelial growth factor-121.2008 Feb 17 [updated 2008 Mar 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Feb 17 [updated 2008 Mar 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641875 Free Books & Documents. Review.
-
Cy5.5-Single-chain Cys-tagged vascular endothelial growth factor-121.2008 Feb 17 [updated 2008 Mar 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Feb 17 [updated 2008 Mar 31]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641371 Free Books & Documents. Review.
-
68Ga-N,N’-bis[2-Hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N’-diacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121.2010 Dec 18 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 18 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348057 Free Books & Documents. Review.
-
68Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121.2010 Nov 17 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Nov 17 [updated 2011 Feb 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21348056 Free Books & Documents. Review.
References
-
- Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004; 25 (4):581–611. - PubMed
-
- Cohen T. , Gitay-Goren H. , Sharon R. , Shibuya M. , Halaban R. , Levi B.Z. , Neufeld G. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem. 1995; 270 (19):11322–6. - PubMed
-
- Soria J.C. , Fayette J. , Armand J.P. Molecular targeting: targeting angiogenesis in solid tumors Ann Oncol 2004 15 Suppl 4iv223–7. - PubMed
-
- Ferrara N. Vascular endothelial growth factor as a target for anticancer therapy Oncologist 2004 9 Suppl 12–10. - PubMed
-
- Hicklin D.J. , Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23 (5):1011–27. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous